Genus plc (LON:GNS - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,795.44 ($24.36) and traded as high as GBX 2,020 ($27.41). Genus shares last traded at GBX 2,020 ($27.41), with a volume of 951,512 shares trading hands.
Wall Street Analyst Weigh In
Separately, Shore Capital reiterated a "buy" rating on shares of Genus in a research note on Wednesday, April 30th.
Check Out Our Latest Research Report on GNS
Genus Price Performance
The firm has a fifty day moving average price of GBX 1,883.20 and a two-hundred day moving average price of GBX 1,795.44. The stock has a market capitalization of £1.30 billion, a P/E ratio of 164.46, a PEG ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.